Digital solutions are needed in healthcare now so that more patients can get the access that they need, according to Vin ...

A small, multi-country analysis of women of child-rearing age has found that these patients experience limits on activities ...

Originally approved by the FDA in September 2023, Biogen's Tofidence became the first tocilizumab biosimilar available in the ...

Participants in the FORWARD-53 trial had clinically significant improvements in time-to-rise, among other metrics.

A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...

By 2023, approximately 1 in 5 patients with non-small cell lung cancer or metastatic colorectal cancer were treated with a bevacizumab biosimilar.

A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...

Cardiac arrests in contemporary film are largely inaccurate when it comes to survival rate and etiology, according to a ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

Marc Humbert, M.D., Ph.D., professor of respiratory medicine at Université Paris-Saclay and Inserm, believes that recent ...